Investigator Sahl takes a comprehensive approach to inspection and values transparency and adherence to procedure. He regards data integrity, procedural consistency, and sound risk management practices as critical to a successful audit. He is quick to identify both systemic and operational deficiencies and will scrutinize processes to ensure adequate controls are in place.

FDA Investigator Wayn Sahl is highly proficient and focused on ensuring full compliance with FDA regulatory requirements, with a particular emphasis on data integrity, procedural and operational controls, and facility maintenance. He pays special attention to the Quality Unit's efficiency and operations. He seems well-versed in assessing systems and maintenance requirements, ensuring that equipment is properly validated, and evaluating the efficiency of control procedures and data integrity measures. He believes in timely issue resolution and expects manufacturing firms to be proactive in addressing and correcting any deviations or non-conformities.